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Disease caused by Neisseria meningitidis is a severe life-threatening infection, with
world-wide incidence of sporadic or epidemic cases (1), and for which no fully effec-
tive vaccine is currently available . Vaccines containing the capsular polysaccharide
provide limited protection against infection caused by strains of serogroups A and
C. However, there is no protection against infection caused by strains of serogroups
AandC. However, there is no protection against group B meningococci, the pre-
dominant cause of infection in many temperate countries, since the group B poly-
saccharide is poorly immunogenic in humans (2) . For these reasons vaccines derived
from outermembranes are currentlybeing evaluated fortheir efficacy in preventing
meningococcal disease(3-6) . Such vaccines which arecomposed of a number of outer
membrane proteins are heterogeneous in their composition and may induce anti-
bodies directed against nonprotective and highly variable antigenic determinants
(4, 6) . An alternative approach is to identify individual proteins that can induce
protective antibodies and thatdo notexhibit excessive antigenic heterogeneity . The
proteins that appear most promising in this respect are theclass 1 and class 2/3 outer
membrane proteins .
All meningococcal isolates contain eitheraclass 2or class3 protein : which is quan-
titatively the majoroutermembrane protein (7) . Expression ofeither protein, which
is stable and mutually exclusive for any individual strain, is controlled by the gene
locus that has recently been designated porB (8, 9) . The proteins function as outer
membrane porins and are therefore analogous to the gonococcal proteins PIA and
PIB. Both the gonococcal porin proteins and meningococcal class 2/3 proteins from
invasive isolates have been shown to spontaneously insert into artificial lipid mem-
branes, suggesting a possible role in tissue invasion (10) .
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SUBTYPE EPITOPES ON MENINGOCOCCAL CLASS 1 PROTEINS
The class 1 protein is also expressed by almost all meningococcal isolates . Its ex-
pression is controlled by the porA gene locus which, unlike those of the other outer
membrane proteins, is not also present in gonococci (8, 9) . Although no biological
role has been unequivocally assigned to the class 1 protein, the predicted amino
acid sequence ofthe porA gene (11) shows considerable homology with the gonococcal
PI proteins (12, 13), suggesting that the protein may play a similar and additional
role to the class 2/3 proteins in meningococcal infection .
Both proteins exhibit differences that generate antigenic diversity between strains .
With the advent ofmAbs it has been possible to define a consistent scheme for desig-
nation of serotype and subtype specificity (14), and to identify the proteins on which
the epitopes reside (15, 16) . Thus, antigenic differences in the class 2/3 outer mem-
brane protein are responsible for serotype specificity, while antigenic determinants
on the class 1 protein generate subtype specificity .
The class 1 protein isunique to meningococci, it is immunogenicand antibodies
directed against it are bactericidal in vitro (3, 5) . mAbs to the class 1 protein also
protect against infection in an experimental animalmodel (17) . Such antibodies are
subtype specific and any vaccine designed to induce a broadly protective immune
response would probably need to contain anumber ofdifferent subtype determinants .
The structure of the epitopes recognized by subtype-specific antibodies is therefore
of considerable interest and importance .
We have previously described the cloning and sequencing ofthe gene from strain
MC50 which is responsible for expression ofthe class 1 protein (11, 18) . In the present
paper we describe the cloning and sequencing of the equivalent gene (porA) from
two further strains of different subtype specificity, and the use ofthe predicted amino
acid sequences to construct synthetic peptides that have been used to define the struc-
ture of the epitopes recognized by a series of subtype-specific mAbs .
Materials and Methods
Meningococcal Strains and Monoclonal Antibodies .
￿
Meningoeoecal strains MC50 (Group C,
type NT, subtype 16 ; C:NT:P1.16) and MC51 (C:NT:P1.15) were from patients with menin-
gococcal disease and were isolated by the Public Health Laboratory Service as described pre-
viously (19) . Strain H44/76 (B :15 :P1.7, 16) was originally obtained from Dr. E . Holten (Na-
tional Institute for Public Health, Oslo, Norway) and is a subtype P1.7, 16 reference strain (14) .
The mAbs directed against class 1 protein have been described previously and are refer-
ence antibodies for determination of subtype specificity (15, 16) .
Cloning andSequence Determination oftheporA Gene.
￿
Previous studies in which the complete
nucleotide sequence of the porA gene from strain MC 50 was obtained revealed that the entire
gene was located on a 2.2-kb Xba I fragment . Chromosomal DNA from strain MC51 was
digested withXba I and fragments of 1.5-2 .5 kb were purified using GENECLEAN' (BIO
101 INC ., LaJolla, California) and ligated in both orientations intoXba I cleaved M13mp18&19
RF DNA . Recombinant plaques were selected that hybridized with the 442-bp EcoRI-Kpn
I fragment from stain MC50 which encompasses the central portion of the porA gene (11) .
Sequencing was carried out by the dideoxy chain termination method usingSEQUENASE'
(U. S . Biologicals, Cleveland, OH) and a previously described series ofsynthetic oligonucleo-
tide primers (11) .
An Eco RI clone from H44/76 carrying the distal two thirds of the class 1 OMP gene
in a kgtll vector was amplified by polymerase chain reaction (PCR) with Xgtll flanking primers .
The amplified fragment ofti2 kb was then cloned into Eco RI cut pUC18, and double-stranded
DNA from this clone was used as template in a standard dideoxynucleotide sequencing reac-
tion . Multiple synthetic sequencing primers were used to extend the sequence obtained withMcGUINNESS ET AL .
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the standard pUC forward primer, and in this way the entire coding strand of the Eco RI
fragment was determined . Separately, the entire class 1OMP gene of H44/76 was amplified
from a chromosomal DNA preparation as described . This amplified 1,340-bp fragment car-
rying the class 1 OMP gene was cloned into M13 vectors and both strands of the DNA se-
quence upstream of the Eco RI site were determined from these clones . In another experi-
ment, a pool of PCRamplified genomic DNA was sequenced directly and a TYR (TAT)
codon was confirmed at amino acid position 203 in contrast to the ASN (AAT) codon seen
in the subclone from Xgt11 obtained after PCR amplification. The direct sequencing data
are probably more representative of the genome sequence than individual clones selected
afterPCR amplification, whichmay carry base changes introduced by polymerase misincor-
poration . This was the only difference seen in over 500 by of sequence obtained by direct
genomic sequencing.
Structural Analysis ofthe Predicted Protein Sequences.
￿
The hydropathy profiles ofthe predicted
protein sequences were calculated using the algorithm of Kyte and Doolittle (20) .
Synthesis of Peptides.
￿
Solid-phase peptide synthesis was carried out using a commercially
available kit (Cambridge Research Biochemicals, Cambridge, UK). The peptides were syn-
thesized on polyethylene rods via a Na-9-fluorenylmethyloxycarbonyl (FMOC) protected a-
alanine link coupled via polyacrylic acid and hexamethylene diamine to the rods (21, 22) .
Pentafluorophenyl (pfp) active esters ofFMOC-L-amino acids with t-butyl side chain pro-
tecting groups were used for the synthesis, except in the case of arginine which had a methoxy-
trimethylphenylsulphonyl side chain protecting group and serine and threonine in which the
oxobenzatriazine active ester was used (Milligen, Watford, UK). All solvents (Romil, Lei-
cester, UK) were of analytical grade and were used without further purification with the ex-
ception of piperidine(BDH, Poole, Dorset, UK), which was redistilled before use and N-N'-di-
methylformamide (DMF) which was stored over molecular sieve(BDH, grade 4A) to remove
amine impurities .
Synthesis was carried out as described previously (23). The (3-alanine was initially depro-
tected by mild base cleavage with piperidine, following which the rods were washed and the
first amino acid was coupled overnight in the presence of hydroxybenzotriazole (as catalyst) .
Deprotection and coupling were repeated for addition of each amino acid required . After
synthesis, the terminal amino groups were acetylated by reaction with acetic anhydride and
amino acid side chain protecting groups were removed by cleavage with trifluoroacetic acid .
Each synthesis was performed in duplicate and control peptides reacting with a mAb sup-
plied by the manufacturer were included to verify the coupling during each synthesis .
Detection ofImmunological Reactivity.
￿
Detection of the immunological reactivities of the syn-
thesized peptides on the rods was performed by ELISA as described previously (23) . The
rods were blocked in PBS containing 1% BSA ; fraction V (Sigma, Poole, Dorset, UK), 1%
ovalbumin (Sigma; grade II), and 0.1% Tween-20 for 1 h at room temperature followed by
incubation with appropriate mAbs diluted 1 :1,000 in the same blocking solution for 18 h
at VC . After washing and reaction with goat anti-mouse IgG-conjugated horseradish per-
oxidase (Bio-Rad Laboratories, Richmond, CA) color was developed using azino-di-3-ethyl-
benzthiazodinsulphonate (ABTS ; Sigma) in substrate buffer (0 .1 M disodium hydrogen or-
thophosphate, 0.08 M citric acid, pH 4.0 with citric acid) as substrate .
The solid-phase peptides were reused after bound antibody was dissociated by sonication
ofthe rods in 1% SDS, 0.1% 2-ME in 0 .1M phosphate buffer at60'C for 30 min . Immuno-
logical reactivity was always observed in duplicate peptides and in assays repeated on at least
two occasions .
Results
Comparison of the PredictedAmino Acid Sequences of Class 1 Proteinfrom ThreeMenin-
gococcal Strains. The predicted amino acid sequences of the class 1 proteins from
three meningococcal strains are shown in Fig . 1 . The proteins showed considerable
structuralhomology with over 90% of the sequences conserved between the strains .
Most of the structural diversity was confined to two major regions, variable region1874
MC50
1144/76
MC51
MC50
H44/76
MC51
SUBTYPE EPITOPES ON MENINGOCOCCAL CLASS 1 PROTEINS
10 20 30
￿
40 50 60 70
DVSLYGEIKAGVEGRNIQAQLTEQPQVTNGVQGNQV---KVTKAKSRIRTKISDFGSFIGFKGSEDLGEGLKAVWQ
. . . . . . . . . . . . . . . .Y .L . . . .AQAANG.AS.- . .KVT . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D . . . . . . .
. . . . . . . . . . . . . . . .F .L . . . .P .SKSQP ..... ...
￿
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
VRI
80 90 100 110 120 130 140
MC50 LEQDVSVAGGGASQWGNRESFIGLAGEFGTLRAGRVANQFDOASQAINPWDSNNDVASQLGIFKRHDOMPVSVRYD
H44/I6 . . . . . . . . . . . .T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MC51
￿
. . . . . . . . . . . .T . . . . . . . .V . . . . . . . . . . . . . . . . . . . . . . . . .D . . . . . . . . . . . . . . . . . . . . . . . . . . . .
160 170 180 190 200 210 220
SPEFSGFSGSVQFVPAQNSKSAYKPAYYTKOTNNNLTLVPAVVGKPGSDVYYAGLNYKNGGFAGNYAFKYARHANV
. . . . . . . . . . . . .I . . . . . . .T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. .p . . . . . . . . . . . .I . . . . . . .T . .H . .RQN .TDV-F . . . . . . . . . . . . . . . . . . . . . . . . . .5 . . . . . . . . . . .
VR2
230 240 250 260 270 280 290 300
MC50 GRNAFELFLIGSATSDEAKGTDPLKNHQVHRLTGGYEEGGLNLALAAQLDLSENGDKAKTKNSTTEIAATASYRFG
1144/76 . . . . . .G- . .Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .
MC51
￿
..p . . . . . .L . ._ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
310 320 330 340 350 360 370
MC50 NAVPRISYAHGFOLIERGKKGENTSYOQIIAGVDYDFSKRTSAIVSGAWLKRNTGIGNYTQINAASVGLRHKF
1144/76 . . . . . . . . . . . . .F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MC51
￿
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FIGURE 1.
￿
Comparative align-
ment of the predicted amino
acid sequencesofthe class 1 pro-
tein from three meningococcal
strains of differing serosubtype
specificities . Numbers indicate
the amino acid position in the
mature class i protein from
strainMC50 (11), dots indicate
identities in the class 1 proteins
of strains MC51 or 1144/76 to
the MC50 sequence, dashes in-
dicate padding characters in-
serted to preserve optimal align-
ment ofthe sequences . The two
major variable domains (VRI
and VR2) are indicated .
1 (VR1) corresponding to amino acid residues 24-36 of the MC50 sequence and
variable region 2 (VR2) corresponding to residues 179-187 . Strains MC50 (subtype
P1.16) and1144/76 (subtype P1.7,16) showed the greatest similarity with major varia-
tions occurring in VRI but not VR2.
Epitope Localization .
￿
Usingthe predicted amino acid sequence of the class 1 outer
membrane proteins a series of solid-phase decapeptides spanning the entire length
ofeach of the three molecules were synthesized, with adjacent peptides overlapping
by five residues . Those peptides were reacted in ELISAwith pairs ofmAbs ofthree
different subtype specificities . In each case thepredominantreactivity was seen with
peptides corresponding to VRI or VR2 (Fig. 1) .
The P1.16-specific mAbs (MN5C11G and 62-D12) both reacted strongly with the
same single decapeptide present inVR2 ofboth P1.16 strains, corresponding to amino
acid residues 176-185 in strain MC50 (P1.16 : Fig. 2, a and b) and residues 178-187
in strain 1144/76 (P1.7, 16 : Fig. 2, c and d) . In addition, the P1.16-specific mAbs
also reacted weakly with peptide 31-40 from VR1 of strain 1144/76 but not with
any peptides from the quite distinct sequence of VR1 from strain MC50 .
Both P1 .7-specificmAbs(MN14C11.6 andADAM 1) reactedwith two overlapping
decapeptides (26-35 and 31-40) from VRI of 1144/76 (Fig . 2, e andf), the only
P1.7 strain, and not with any other sequences .
Unlike the other pairs of mAbs, which showed very similar reactivities, the two
P1.15-specific mAbs (MN3C5C and 93115) had quite distinct properties . Antibody
93115 failed to react with any of the linear peptides tested (Fig. 2 h) . In contrast
antibodyMN3C5C reacted strongly notonly with two overlapping peptides inVR2
of theMC51 sequence (172-181 and 177-186), but also with anumber of other pep-
tides towards the COOH terminus in the more conserved regions of the molecule
(Fig . 2 g) .
Epitope Definition.
￿
In an attempt to precisely define the epitopes recognized by
each of the subtype-specific mAbs a series of solid-phase decapeptides were synthe-McGUINNESS ET AL .
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FIGURE 2 .
￿
Epitope scanning by reaction of mAbs with solid-phase decapeptides spanning the
predictedamino acid sequences ofclass 1 proteins from strainsMC50, MC51, andH44/76 . Ad-
jacent decapeptides differ by five amino acid residues . Annotations show the strain from which
the sequence was derived, the mAb used, and its subtype specificity .
sized spanning each of theVR1 andVR2 sequences, and also the other regions of
reactivity in the MC51 sequence, in which adjacent peptides differed by a single
amino acid . Subsequently, a further series of smaller peptides covering the regions
of interest were synthesized to establishthe minimumreactive epitope foreach mAb.1876
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(a) Subtype P1.16.
￿
The P1.16-specific mAbs reacted with the same five adjacent
overlapping decapeptides (Fig. 3, a-d) from VR2 of both P1.16 strains. In either
case, optimal reactivity was seen with the peptideTKDTNNNLTL and each of the
reacting peptides had in common the sequence KDTNNN . A slight difference was
seen in the reactivity of the two antibodies with small peptides, while MN5C11G
FIGURE 3 .
￿
Reaction of themAbs with seriesofoverlapping decapeptides correspondingto vari-
able regions VRl and VR2, with adjacent peptides differing by a single amino acid residue.
Annotations show the strain from which the sequence was derived, themAbused,and its subtype
specificity.McGUINNESS ET AL .
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showed significant reactivity with the hexa~eptideKDTNNN thiswasconsiderably
less with 62-D12 (Fig . 4, aand b) . Thus, at the levelof resolution possible, it appears
that the two P1.16-specific mAbs recognize almost but not quite identical epitopes
in VR2 of the P1.16 strains .
Theadditional weak reactivity ofboth P06-specificmAbs inVRl of strain H44/76
FIGURE 4.
￿
Determination oftheminimum linear epitopes recognized by mAbs . Each antibody
was reacted with a series of oligopeptides contained within the decapeptides found to be recog-
nized in figure 3 . Annotations show the relevant variable region, the strain from which the se-
quence was derived, the mAb used, and its subtype specificity.1878
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was localized to five adjacent overlappingdecapeptides containing the common se-
quence ASGQVK (Fig. 3, cand d) . Although in each case MN5C11G reacted more
strongly than 62-1312, the pattern of reactivity with small peptides was identical .
Both reacted with the two octapeptides, they reacted strongly with only one of the
hexapeptides (ASGQVK) and neither recognized any of the tetrapeptides made of
this VR1 (Fig . 4, c and d) .
(b) Subtype P1.7.
￿
The two P1.7-specific mAbs both reacted with eight adjacent
overlapping decapeptides in VRl of strain H44/76, containing thecommon sequence
SGQ(Fig. 3, e andf) . Both also reacted strongly with the two octapeptides synthe-
sized and with two of the hexapeptides (ASGQVK and SGQVKV), but not with
the third (GQVKVT), and with only one of the tetrapeptides (ASGQ) (Fig. 4, e
andf). Thus, MN14CIL6 andADAM 1 have very similar specificities for the linear
peptides from VRI of the P1.7 strain, with the sequence SGQ, corresponding to
residues 32-34, being necessary although not entirely sufficient for reactivity .
(c) Subtype P1.15.
￿
As with the preliminary scanning experiments (Fig . 2 h) no
reactivity ofmAb 93H5 could be seen with any of the overlappingdecapeptides cor-
responding to VRl or VR2 of strain MC51, suggesting that theepitope recognized
is not a simple linear peptide but rather involves a particular conformation of the
protein overa more extended region . Antibody MN3C5C reacted with eight adja-
cent overlapping decapeptides in VR2 ofMC51 with the common sequence NNT
(Fig. 3 g) . In addition the antibody reacted with a varietyof smaller peptides ranging
from octamers to trimers all ofwhich contained NNT (fine tuning of this epitope
showed that MN3C5C reacted with all peptides ranging in size from decapeptides
down to tripeptides which contained NNT [Fig . 4 g]) . When the additional reac-
tivity of MN3C5C with peptides in the conserved regions was examined in more
detail itwas found that MN3C5C reacted most strongly with two groups of five ad-
jacent overlappingdecapeptides that contained the sequences NST and NTS, respec-
tively. Subsequent reaction with a number of di- and tripeptides revealed that the
antibody recognized tripeptides of the form NXT or NXS (where X = N, T, S,
or L), suggesting that the additional reactivity of MN3C5C was due to a relatively
low specificity and the occurrence of these sequences elsewhere in the molecule .
Discussion
Comparison of the predicted amino acid sequence of the three class 1 protein se-
quences now available reveals considerable structural homology with major varia-
tion confined to only two discrete regions (VR1 and VR2) . StrainMC51 differs from
the previously published sequence of strain MC50 in only 25 of 374 residues, 13
of these differences occurring in either VR1 or VR2. While the differences between
the variable regions involve insertions, deletions, or substitutions of unlike amino
acids, the differences seen in the conserved regions generally involve only conserva-
tive substitutions of similar aminoacids . The high degree of homology between the
three sequences results in predicted secondary structures that are almost identical,
indicating a highly conserved functional role for the protein in outer membranes
ofmeningococci . The previously noted similarity ofclass 1 protein from strainMC50
with gonococcal PI (11) indicates that this role is to act as a hydrophilic diffusion
pore. This function has been concerned_ by recent studies that have demonstratedMcGUINNESS ET AL.
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that class 1 protein inserted into artificial membranes acts as a slightly cation selec-
tive porin (Tommasson,J., andJ . T . Poolman, unpublished observations) . Like strain
MC50 (11), strains MC51 and H44/76 also show alternatingdomains ofhydrophilic
and hydrophobic amino acids. Similar patterns are seen with Escherichia coli outer
membrane porin proteins, and combined with x-ray diffraction data and antigenic
analysis this has led to models for porin proteins in which a series of hydrophilic
surface exposed regions are separated by membrane spanning 0-sheets (24, 25).
Thelocation of antigenic subtype specificityon the class 1 proteins focuses partic-
ular attention on differences between the strains, since these must clearly form the
basis of antigenic diversity. The existence of only two major variable regions is in
accord with the previous studies with mAbs that suggested that the class 1 proteins
contain two independent subtype-specific epitopes (15) . Comparison of the sequences
suggests that these must correspond to VRI andVR2. This is also in accord with
the positions of the two variable regions within the molecule . Examination of the
hydropathy profile of the MC50 class 1 protein (11) reveals that both are located in
hydrophilic domains that are likely to be surface exposed and hence accessible to
antibody binding .
The localization of linear epitopes recognized by mAbs has been greatly facili-
tatedby the developmentoftechniques for rapid, concurrent synthesis oflargenumbers
ofpeptides fordirect testing byELISA (21, 22). Using this technique haspermitted,
with the exception ofmAb 93H5, precise definition ofshort peptides that constitute
the epitopes recognized by the subtype-specific mAbs . The results confirm the inde-
pendent influence of sequence variations in VRI andVR2 in generating two sub-
type specificities within each class 1 protein molecule . Thus, the P1.7 epitope is as-
sociated with a specific sequence in VRI while the P1.16 epitope lies within VR2 .
Hence, strain H44/76, which contains the P1.7 sequence 31ASGQ4 in VRl and the
P1.16 sequence 119KIYFNNN184 in VR2, is subtype P1.7, 16 while strain MC50
which contains 1s1KDTNNN 1s6 in VR2 but has an entirely different sequence in
VRl is subtype P1.16 . Similarly theparticular sequence found inVR2 ofstrain MC51
is sufficient to define it as subtype P1.15 . However, the sequence recognized by the
P1.15 antibody MN3C5C shows low specificity, recognizing not only the sequence
NNT, which occurs in VR2 of strain MC51, but also NXT or NXS (whereX =
N, L, S, or T), whichoccur in theconserved regions at positions 287-289 and 324-326 .
Although these latter two sequences are also present in the twoothersubtype strains,
antibody MN3C5C is specific for subtyping P1.15 strains (16) . Presumably because
these regions, unlike VR2, lie in the morehydrophobic regions of the class 1 protein
molecule they are not exposed on the surface and hence unavailable for antibody
binding to intact cells in the usual subtyping procedure.
Although most of the above data are consistent with a model in which linear se-
quences in each of the variable regions independently define with two subtypes of
any strain, the situation in one case at least must be more complex than this . Both
P1.16 specific antibodies recognize theKI7TNNN sequence present in VR2 ofstrains
MC50 and H44/76 but they also exhibit weaker reaction with the apparently un-
related sequenceASGQVK inVRI ofH44/76 . Sincethe latter sequence is not present
in strain MC50 it is clearly not necessary for subtype specificity. Nevertheless, it
suggests that the quaternary structureofthe native molecule is such that while the1880
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dominant factor in generation of the PI-16 epitope is the contribution from VR2,
there is an additional influence ofVRl in generating thecomplexthree-dimensional
structure of the molecule. If this is the case itwould seem likely that similar interac-
tions may well occur with other subtype specificities .
The separate influence of VRl andVR2 on subtype specificity implies that all
meningococcal strains wouldexhibit twodistinct subtype specificities . Thus, sequences
found within theVRl regions of strainsMC50 andMC51 therefore represent addi-
tional, undefined, subtype-specific regions for which the corresponding mAbs have
not yet been produced . These data suggest that similar as yet undefined subtype
specificities arepresent on the class 1 proteins ofall strains whereonly one specificity
has so far been defined.
A particularly important implication of the current study lies in the fact that the
mAbs used are bactericidal (5) andprotect infant rats from challenge with heterolo-
gous strains of the same subtype (17) . Indeed, when compared with antibodies directed
against other surface antigens, the anti-class 1 antibodies were found to have the
greatest protective effect in the infant rat model (26) . Thus we have been able to
define linear epitopes on the class 1 protein that are notonly responsible forsubtype
specificity butthat representeffective targets for a protective immune response . Any
vaccine strategy based on the variable epitopes identified in VRl and VR2 would
limit protection to strains of the same sero-subtype and would therefore necessitate
a polyvalent vaccine . However, the techniques used in the current study may ulti-
mately lead to theidentification ofmore conserved, but less immunogenic, epitopes
on the class 1 protein that provide alternative targets for vaccination . Indeed solid-
phasepeptide synthesis has alreadybeen used to identify the conserved epitope rec-
ognized by a protective mAb on the related gonococcal protein I and immunization
with a synthetic peptide containing the epitope was found to induce a bactericidal
immune response (27) . Such studies suggest that the ultimate goal of an effective
vaccine against all meningococcal infection may be a realistic possibility .
Summary
The previously determined nucleotide sequence of the porA gene, encoding the
class 1 outer membrane protein of meningococcal strain MC50, has been used to
clone and sequence the porA gene from two further strains with differing serosub-
type specificities . Comparison of the predicted amino acid sequences of the three
class 1 proteins revealed considerable structural homology with major variation
confined to two discrete regions (VRI andVR2) . The high degree of structural ho-
mology between the sequencesgave predicted secondarystructures that were almost
identical, with the variable domains located in hydrophilic regions that are likely
to be surface located and hence accessible to antibody binding.
The predicted amino acid sequenceshave been used to define the epitopes recog-
nized by mAbs with serosubtype specificity. A series of overlapping decapeptides
spanning each ofthe class 1 protein sequences have been synthesized on solid-phase
supports and probed withmAbs . Antibodies with P1.16 andP1.15 subtype specificity
reacted with sequences in the VR2 domain, while antibodies with P1.7 subtype
specificity reacted with sequences in the VRl domain . Further peptides have been
constructed to define the minimum epitopes recognized by each antibody. Thus we
have been able to define linear peptides on each class 1 protein molecule that areMcGUINNESS ET AL .
￿
1881
responsible for subtype specificity and that represent targets for a protective im-
mune response .
Receivedfor publication 21 December 1989 and in revisedform 12 February 1990.
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